Contact
Please use this form to send email to PR contact of this press release:
Dermira Announces Early Termination of the Hart-Scott-Rodino Waiting Period for License to Lebrikizumab
TO:
Please use this form to send email to PR contact of this press release:
Dermira Announces Early Termination of the Hart-Scott-Rodino Waiting Period for License to Lebrikizumab
TO: